Background The production of peroxide and superoxide is an inevitable consequence of aerobic metabolism, and while these particular'reactive oxygen species'(ROSs) can exhibit a …
S Ananiadou, DB Kell, J Tsujii - Trends in biotechnology, 2006 - cell.com
With biomedical literature increasing at a rate of several thousand papers per week, it is impossible to keep abreast of all developments; therefore, automated means to manage the …
Unlike signalling pathways, metabolic networks are subject to strict stoichiometric constraints. Metabolomics amplifies changes in the proteome, and represents more closely …
D Hull, SR Pettifer, DB Kell - PLoS computational biology, 2008 - journals.plos.org
Many scientists now manage the bulk of their bibliographic information electronically, thereby organizing their publications and citation material from digital libraries. However, a …
IV Tetko - Drug discovery today, 2005 - academia.edu
Despite the dramatic growth of the Internet, the number of practical applications in drug design, particular for prediction ADME/T properties, which are available on-line remains …
WJ Geldenhuys, KE Gaasch, M Watson, DD Allen… - Drug discovery today, 2006 - Elsevier
Drug discovery is a time consuming and costly process. Recently, a trend towards the use of in silico computational chemistry and molecular modeling for computer-aided drug design …
O Spjuth, T Helmus, EL Willighagen, S Kuhn… - BMC …, 2007 - Springer
Background There is a need for software applications that provide users with a complete and extensible toolkit for chemo-and bioinformatics accessible from a single workbench …
DB Kell - The FEBS journal, 2006 - Wiley Online Library
The newly emerging field of systems biology involves a judicious interplay between high‐ throughput 'wet'experimentation, computational modelling and technology development …
MP Mazanetz, RJ Marmon… - Current topics in …, 2012 - ingentaconnect.com
Technological advances in high-throughput screening methods, combinatorial chemistry and the design of virtual libraries have evolved in the pursuit of challenging drug targets …